Vesalius Therapeutics

AI drug discovery using patient cell analysis

Vesalius is redefining how we define and treat common illnesses. Common illnesses such as heart failure, high blood pressure, type II diabetes and obesity have a single diagnosis, yet are each a constellation of multiple genetic and biologically distinct diseases which affect patients differently. Vesalius is using their DIAMOND product-platform to discern previously unrecognized clinical patterns in groups of patients and link them to genetic differences to identify the cause of disease. The DIAMOND platform creates proprietary patient-derived experimental models that can be used to screen and characterize drug candidates to restore healthy function. Vesalius’ approach also depends upon AI and machine learning to combine human data with genomics information.